questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiologiques respiratoires
Capacité pulmonaire totale
Capacité vitale
Capacité vitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Spirométrie
Fonction pulmonaire
Pléthysmographie
Gaz du sang
Capacité vitale
Normes physiologiques
Dyspnée
Maladies pulmonaires
Symptômes
5
Essoufflement
Oppression thoracique
Douleurs thoraciques
Cyanose
Âge
Dégradation pulmonaire
Prévention
5
Tabagisme
Activité physique
Vaccins
Infections respiratoires
Exercice physique
Fonction pulmonaire
Hydratation
Voies respiratoires
Traitements
5
Réhabilitation pulmonaire
Bronchodilatateurs
Physiothérapie
Fonction pulmonaire
Médicaments
Bronchodilatateurs
Complications
5
Insuffisance respiratoire
Infections pulmonaires
Capacité vitale
Complications respiratoires
Maladies cardiaques
Capacité vitale
Infections pulmonaires
Inflammation
Effets à long terme
Santé respiratoire
Facteurs de risque
5
Âge
Dégradation pulmonaire
Environnement de travail
Pollution
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité vitale : Questions médicales les plus fréquentes",
"headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité vitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Capacité pulmonaire totale",
"url": "https://questionsmedicales.fr/mesh/D014109",
"about": {
"@type": "MedicalCondition",
"name": "Capacité pulmonaire totale",
"code": {
"@type": "MedicalCode",
"code": "D014109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve expiratoire",
"alternateName": "Expiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D005105",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve expiratoire",
"code": {
"@type": "MedicalCode",
"code": "D005105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Capacité inspiratoire",
"alternateName": "Inspiratory Capacity",
"url": "https://questionsmedicales.fr/mesh/D007320",
"about": {
"@type": "MedicalCondition",
"name": "Capacité inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve inspiratoire",
"alternateName": "Inspiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D007321",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Volume courant",
"alternateName": "Tidal Volume",
"url": "https://questionsmedicales.fr/mesh/D013990",
"about": {
"@type": "MedicalCondition",
"name": "Volume courant",
"code": {
"@type": "MedicalCode",
"code": "D013990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Capacité vitale",
"alternateName": "Vital Capacity",
"code": {
"@type": "MedicalCode",
"code": "D014797",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Toby M Maher",
"url": "https://questionsmedicales.fr/author/Toby%20M%20Maher",
"affiliation": {
"@type": "Organization",
"name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA."
}
},
{
"@type": "Person",
"name": "Hyun Lee",
"url": "https://questionsmedicales.fr/author/Hyun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Hye Yun Park",
"url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Masato Kono",
"url": "https://questionsmedicales.fr/author/Masato%20Kono",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A simplified HPLC-based method for measuring unconjugated bilirubin, bilirubin-monoglucuronide, bilirubin-diglucuronide, and delta-bilirubin in plasma with increased conjugated bilirubin.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36534490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00365513.2022.2155989"
}
},
{
"@type": "ScholarlyArticle",
"name": "The use of transcutaneous bilirubin nomograms for the prevention of bilirubin neurotoxicity in the neonates.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37538268",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1212667"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bilirubin Encephalopathy.",
"datePublished": "2022-05-19",
"url": "https://questionsmedicales.fr/article/35588044",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11910-022-01204-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bilirubin Prevents the TH",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36430754",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232214276"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optoacoustic monitoring of bilirubin photodegradation.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37345342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jbio.202200339"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012143"
},
{
"@type": "ListItem",
"position": 4,
"name": "Capacité pulmonaire totale",
"item": "https://questionsmedicales.fr/mesh/D014109"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité vitale",
"item": "https://questionsmedicales.fr/mesh/D014797"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité vitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité vitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité vitale",
"description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité vitale",
"description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité vitale",
"description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité vitale",
"description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité vitale",
"description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité vitale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Bilirubin#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité vitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests complètent l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères normaux de capacité vitale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L."
}
},
{
"@type": "Question",
"name": "Quand suspecter une capacité vitale réduite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème pulmonaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une capacité vitale faible ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique."
}
},
{
"@type": "Question",
"name": "La toux est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la réduction de la capacité vitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certaines expositions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire."
}
},
{
"@type": "Question",
"name": "L'hydratation est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent la capacité vitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle utile ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la cause ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "La capacité vitale faible augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les infections affectent-elles la capacité vitale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la capacité vitale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne."
}
},
{
"@type": "Question",
"name": "L'environnement de travail est-il un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Imperial College London, London, UK.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
University of California San Francisco, 8785, San Francisco, California, United States.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium; Department of Geriatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: ivan.bautmans@vub.be.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Ageing and Health Unit, WHO, Geneva, Switzerland.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, Australia; Yong Loo Lin School of Medicine, Centre for Healthy Longevity, National University of Singapore, Singapore; National University Health System, Singapore.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Institute for Biomedicine of Aging, University of Erlangen-Nuremberg, Nuremberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Faculty of Sciences, Department of Exercise Sciences, Université du Québec à Montréal, QC, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Weill Cornell Medicine, New York, New York, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
Prolonged icterus is an important and common problem in neonatology and accurate determination of the different bilirubin species, including differentiation between delta-bilirubin and mono- and di-co...
Although neonatal jaundice is a ubiquitous and predominantly benign phenomenon, the risk of neurotoxicity exists in a number of infants with unconjugated hyperbilirubinemia. Plotting bilirubin values ...
TcB measurements were taken in infants at ages ranging from 0 to 96 postnatal hours. We then constructed hour-specific TcB nomograms from forehead and sternum measurements in infants who did not requi...
We included 2,981 TcB measurements taken on the forehead and 2,977 measurements taken on the sternum in 301 White term newborn infants. We assessed the predictive abilities of the nomograms at six pos...
The nomograms illustrate dermal bilirubin dynamics in White term neonates during the first 4 days of life. They may be useful tools to predict individualized risk of hyperbilirubinemia requiring treat...
Hyperbilirubinemia is commonly seen in neonates. Though hyperbilirubinemia is typically asymptomatic, severe elevation of bilirubin levels can lead to acute bilirubin encephalopathy and progress to ke...
The understanding of the genetic and biochemical processes that increase the susceptibility of defined anatomical areas of the central nervous system to the deleterious effects of bilirubin may facili...
Parkinson's disease (PD), the fastest-growing movement disorder, is still challenged by the unavailability of disease-modifying therapy. Mildly elevated levels of unconjugated bilirubin (UCB, PubChem ...
Hematomas resulted from trauma are very common, and the efficacy of existing treatment techniques is limited. Phototherapy can be used to expedite healing and improve the appearance of the damaged tis...
Dopamine is a well-known neurotransmitter due to its involvement in Parkinson's disease (PD). Dopamine is not only involved in PD but also controls multiple mental and physical activities, such as the...
Oxidative stress and its role in the pathogenesis of cutaneous diseases have been widely investigated. However, there are few studies that have solely assessed the contribution of intracellular antiox...
This study aimed to determine serum levels of two major extracellular antioxidants (Bil and UA) levels in patients with melasma and their correlation with the severity and extent of the disease....
In this case-control study, the serum levels of bilirubin and uric acid of 50 melasma patients were compared with 50 healthy controls. Moreover, the correlation of serum concentrations of these antiox...
The serum concentration of Bil was significantly higher in the case group (p < 0.05). Furthermore, serum Bil level had a positive correlation with the extent of the melasma (correlation coefficient, +...
Oxidative stress may play a major role in the etiopathology of melasma and bilirubin, as an antioxidant, could be involved in the process of oxidative stress....
The accumulation of bilirubin in blood is associated with many diseases. Sensitive and accurate detection of bilirubin is of great significance for personal health care. The rapid development of fluor...
Exposing blood serum samples to ambient white light-emitting diode (WLED) light may accelerate bilirubin photoisomer production. We previously demonstrated the quantitative effect of bilirubin configu...
In Study 1, the relationship between WLED irradiation time and BSI production was examined. Serum samples from five neonates were irradiated with WLED light for 0, 10, 30, 60 and 180 min. Bilirubin is...
In Study 1, the median BSI production rate was 0.022 mg/dL per min in specimens with an unconjugated bilirubin concentration of 10.88 mg/dL. In Study 2, assuming that ⊿DB-0.19*⊿BCI was...
Under ambient WLED light, serum sample generated 1.3 mg/dL BSIs in 1 h. Approximately 34% (0.44 mg/dL) of BSI concentrations was measured as DB when using the vanadate oxidation method according to th...
The aim of this study is to determine the value of the questions asked in routine follow-up, the cord blood bilirubin (CBB) and bilirubin/albumin (B/A) ratio in estimating the risk of developing hyper...
Term and healthy 217 newborns whose CBB and albumin could be obtained and whose needed to be measured bilirubin level at the 24thand 72nd hours of life were included. Nutrition, sex and nationality, c...
CBB and cord B/A ratio, STB and serum B/A ratio, and TcB at the 24th and 72nd hours were found to be higher in the babies who received the phototherapy (p < 0.001 for all). The moderate positive corre...
CBB and B/A ratio are important in predicting the possibility of indirect hyperbilirubinemia (IHB) development. Babies should be followed closely in terms of IHB development when their CBB value is 1....